Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLAU | P00749 | 4/20 | 0.49 |
| ▸ | F2 | P00734 | 3/20 | 0.49 |
| ▸ | PLAT | P00750 | 3/20 | 0.49 |
| ▸ | CA12 | O43570 | 2/20 | 0.48 |
| ▸ | CA1 | P00915 | 2/20 | 0.48 |
| ▸ | CA2 | P00918 | 2/20 | 0.48 |
| ▸ | CA9 | Q16790 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | PLG | P00747 | 2/20 | 0.46 |
| ▸ | KLK8 | O60259 | 1/20 | 0.46 |
| ▸ | F10 | P00742 | 1/20 | 0.46 |
| ▸ | KLK4 | Q9Y5K2 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.45 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.45 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL15251731 | 0.99 | PLAU (0.48) | PLAUF2PLATCA12CA1 | |
| SCHEMBL5845871 | 0.88 | NR4A1 (0.51) | PLAUCA12CA1CA2CA9 | |
| SCHEMBL10942377 | 0.88 | LMNA (0.59) | PLAUCA12CA1CA2CA9 | |
| SCHEMBL28842161 | 0.87 | PLAU (0.50) | PLAUF2PLATCA12CA1 | |
| SCHEMBL1457681 | 0.87 | PLAU (0.49) | PLAUF2PLATCA12CA1 | |
| SCHEMBL7450597 | 0.87 | CTRB1 (0.49) | PLAUF2PLATCA12CA1 | |
| Hydrochloric Acid SCHEMBL15251794 | 0.87 | PLAU (0.48) | PLAUF2PLATCA12CA1 | |
| SCHEMBL23511586 | 0.86 | MEN1 (0.54) | PLAUF2PLATCA1CA2 | |
| Hydrochloric Acid SCHEMBL5846787 | 0.86 | PLAU (0.48) | PLAUF2PLATCA12CA1 | |
| SCHEMBL7442011 | 0.86 | ALDH1A1 (0.50) | PLAUF2PLATCA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1995018619-A9 | BICYCLIC FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 2004-10-21 | — | — | WO | disclosed |
| EP-1102746-B1 | SUBSTITUTED PHENYLAMIDINES WITH ANTITHROMBOTIC ACTION | BOEHRINGER INGELHEIM PHARMA (DE) | 2003-05-14 | — | — | EP | disclosed |
| EP-0593603-B1 | BICYCLIC FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 2002-11-20 | — | — | EP | disclosed |
| US-6403578-B1 | ANTICOAGULANTS, CARDIOVASCULAR DISORDERS | SMITHKLINE BEECHAM CORPORATION | 2002-06-11 | — | — | US | disclosed |
| US-6242466-B1 | ANTICOAGULANTS, ANTITUMOR, ANTIMETASTASIS, ANTICARCINOGENIC, AND ANTIINFLAMMATORY AGENTS; BONE DISORDERS | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2001-06-05 | — | — | US | disclosed |
| EP-1102746-A1 | SUBSTITUTED PHENYLAMIDINES WITH ANTITHROMBOTIC ACTION | BOEHRINGER INGELHEIM KG (DE) | 2001-05-30 | — | — | EP | disclosed |
| US-6127359-A | Bicyclic fibrinogen antagonists | SMITHKLINE BEECHAM CORPORATION (US) | 2000-10-03 | — | — | US | disclosed |
| US-6117866-A | Bicyclic fibrinogen antagonists | SMITHKLINE BEECHAM CORPORATION (US) | 2000-09-12 | — | — | US | disclosed |
| WO-2000005207-A1 | SUBSTITUTED PHENYLAMIDINES WITH ANTITHROMBOTIC ACTION | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2000-02-03 | — | — | WO | disclosed |
| US-5939412-A | Bicyclic fibrinogen antagonists | SMITHKLINE BEECHAM CORPORATION (US) | 1999-08-17 | — | — | US | disclosed |
| US-5693636-A | Bicyclic fibrinogen antagonists | SMITHKLINE BEECHAM CORPORATION (US) | 1997-12-02 | — | — | US | disclosed |
| EP-0738150-A4 | BICYCLIC FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 1997-03-19 | — | — | EP | disclosed |
| EP-0738150-A1 | BICYCLIC FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1996-10-23 | — | — | EP | disclosed |
| EP-0674623-A1 | BICYCLIC FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1995-10-04 | — | — | EP | disclosed |
| WO-1995018619-A1 | BICYCLIC FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1995-07-13 | — | — | WO | disclosed |
| WO-1994014776-A2 | BICYCLIC FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1994-07-07 | — | — | WO | disclosed |
| EP-0593603-A1 | BICYCLIC FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1994-04-27 | — | — | EP | disclosed |
| WO-1993000095-A2 | BICYCLIC FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1993-01-07 | — | — | WO | disclosed |